Natera, Illumina Ink Deal To End Row Over DNA Testing IP

Illumina Inc. and Natera Inc. have agreed to drop dueling patent infringement claims over fetal DNA testing technology in California federal court and to firm up a licensing agreement, according to a newly submitted regulatory filing…

Read this piece in its entirety at Law360.

Comments

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s